4 Fresh Biotech Stock Picks With Targets 50% to 100% Higher
In the past week there were four analyst picks in and associated with the biotech area that came with gigantic upside price targets.
In the past week there were four analyst picks in and associated with the biotech area that came with gigantic upside price targets.
Fitch said that its A- rating on the NBA are meant to reflect the underlying core economic model of the organization.
Investors in Petrobras have to be wondering about the fate of its dividend. The Brazilian state-run oil giant remains in a very difficult position.
Market pundits and economists have been predicting a rise in the federal funds rate for quite some time, and the first fed funds rate hike still seems likely to occur in 2015.
While companies do not like to cut their dividends, 24/7 Wall St. has identified four companies that actually may have to do so.
Thursday's top analyst upgrades and downgrades include Garmin, IMAX, Micron Technology, Kimberly-Clark and Procter & Gamble.
Twitter has recovered handily from its post-IPO lows, and now the stock has been started as Buy with a whopping $65 price target at Jefferies.
What investors need to know is that analysts are cooling on their view of a potential Altera-Intel deal.
The Brewers Association has released its 2014 data on U.S. craft brewing, and it shows that craft brewers have now reached double-digit volume share of the marketplace for the first time ever.
Manufacturing ISM Report on Business for the month of March was above the breakeven level, but it was shy of the Bloomberg consensus estimate.
Friday's unemployment and payrolls report from the U.S. Labor Department just became a lot more difficult to predict.
Wednesday's top analyst upgrades and downgrades include Alibaba, Altera, Dyax, Hewlett-Packard, Kinder Morgan, Michael Kors, Staples and Twitter.
What are investors supposed to think after the chairman of Chesapeake Energy made a purchase larger than most people will make in their entire lives?
24/7 Wall St. could not help but notice that several of the 30 Dow Jones Industrial Average components are trading close to their 52-week lows.
Tuesday's top analyst upgrades and downgrades include Brocade Communications, IAC/InterActiveCorp, Nabors Industries, Priceline, Teva Pharmaceutical and Yamana Gold.
24/7 Wall St. has not been overly concerned about Chevron's dividend -- we still see it hiking the dividend minimally.
What does a visionary CEO like Elon Musk do when he sees that his shares of Tesla Motors are close to 52-week lows and down over 35% from their highs?
The Federal Reserve Bank of Dallas has released its Manufacturing Outlook report for the month of March, the first negative reading on Texas manufacturing in nearly two years.
Catamaran, a provider of pharmacy benefit management services and technology solutions, announced Monday morning that it has agreed to merge with OptumRx.
Monday's top analyst upgrades and downgrades include Altera, Delta Air, Devon Energy, General Motors and Micron Technology.